AgeX Therapeutics Reports First Quarter 2023 Financial Results
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.Balance Sheet InformationCash, cash equivalents, and restricted cash...
United States Agex Therapeutics Inc Exchange Commission Serina Therapeutics Inc Agex Therapeutics Juvenescence Limited
Source: pharmiweb.com